vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and Principal Financial Group (PFG). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $750.8M, roughly 7.3× Principal Financial Group). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 0.3%, a 7.7% gap on every dollar of revenue. On growth, Principal Financial Group posted the faster year-over-year revenue change (4.0% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Principal Financial GroupPFGEarnings & Financial Report
Principal Financial Group, Inc. (PFG) is an American global financial investment management and insurance company headquartered in Des Moines, Iowa, United States.
FMS vs PFG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $750.8M |
| Net Profit | $434.2M | $1.9M |
| Gross Margin | 27.4% | — |
| Operating Margin | 11.7% | — |
| Net Margin | 7.9% | 0.3% |
| Revenue YoY | -0.3% | 4.0% |
| Net Profit YoY | 240.4% | 783.0% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $750.8M | ||
| Q4 25 | $5.5B | $4.6B | ||
| Q3 25 | — | $3.7B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $3.7B | ||
| Q4 24 | $5.5B | $4.8B | ||
| Q3 24 | — | $3.0B | ||
| Q2 24 | — | $4.3B |
| Q1 26 | — | $1.9M | ||
| Q4 25 | $434.2M | $517.0M | ||
| Q3 25 | — | $213.8M | ||
| Q2 25 | — | $406.2M | ||
| Q1 25 | — | $48.1M | ||
| Q4 24 | $127.6M | $905.4M | ||
| Q3 24 | — | $-220.0M | ||
| Q2 24 | — | $353.1M |
| Q1 26 | — | — | ||
| Q4 25 | 27.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 5.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | 0.3% | ||
| Q4 25 | 7.9% | 11.3% | ||
| Q3 25 | — | 5.8% | ||
| Q2 25 | — | 11.1% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | 2.3% | 19.1% | ||
| Q3 24 | — | -7.3% | ||
| Q2 24 | — | 8.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.30 | ||
| Q3 25 | — | $0.95 | ||
| Q2 25 | — | $1.79 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $3.92 | ||
| Q3 24 | — | $-0.95 | ||
| Q2 24 | — | $1.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.4B | — |
| Total Assets | $33.5B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $4.4B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $3.9B | ||
| Q4 24 | $1.3B | $4.2B | ||
| Q3 24 | — | $6.2B | ||
| Q2 24 | — | $4.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.9B | ||
| Q3 25 | — | $3.9B | ||
| Q2 25 | — | $3.9B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $3.9B |
| Q1 26 | — | — | ||
| Q4 25 | $15.4B | $11.9B | ||
| Q3 25 | — | $11.7B | ||
| Q2 25 | — | $11.4B | ||
| Q1 25 | — | $11.2B | ||
| Q4 24 | $17.0B | $11.1B | ||
| Q3 24 | — | $11.2B | ||
| Q2 24 | — | $11.0B |
| Q1 26 | — | — | ||
| Q4 25 | $33.5B | $341.4B | ||
| Q3 25 | — | $334.5B | ||
| Q2 25 | — | $323.1B | ||
| Q1 25 | — | $313.0B | ||
| Q4 24 | $36.3B | $313.7B | ||
| Q3 24 | — | $322.9B | ||
| Q2 24 | — | $308.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.39× | ||
| Q4 24 | — | 0.36× | ||
| Q3 24 | — | 0.35× | ||
| Q2 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 6.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $1.7B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $811.9M | ||
| Q1 25 | — | $977.3M | ||
| Q4 24 | $2.6B | $1.5B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | 6.67× | 3.37× | ||
| Q3 25 | — | 4.70× | ||
| Q2 25 | — | 2.00× | ||
| Q1 25 | — | 20.32× | ||
| Q4 24 | 20.20× | 1.61× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 4.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
